20 Dec 2012 17:35
20 December 2012
Akers Biosciences, Inc.
("ABI" or the "Company")
Result of Annual General Meeting
ABI, a leading designer and manufacturer of rapid diagnostic screening and testing products, announces that all resolutions proposed at the Annual General Meeting of the Company, held today, were duly passed.
Enquiries:
Thomas A. Nicolette
President and CEO
Tel. +1 856 848 8698
Antony Legge or Emma Earl
Daniel Stewart & Company plc (Nomad and Broker)
Tel. +44 (0)20 7776 6550
Akers Biosciences develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health status information, both rapidly and directly, to the consumer or healthcare provider. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere, in minutes, since time is always of essence. ABI is aligned with high volume medical product distributors to help facilitate the Company's growth into a major, worldwide competitor in the field of rapid diagnostics. Additional information on the Company and its products can be found at www.akersbiosciences.com